References
- Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 2010;125:S53–72
- Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000;47:87–103
- Petraglia F, Florio P, Benedetto C, et al. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J Clin Endocrinol Metab 1996;81:852–56
- Lessan-Pezeshki M. Pregnancy after renal transplantation: points to consider. Nephrol Dial Transplant 2002;17:703–7
- Davison JM. Dialysis, transplantation, and pregnancy. Am J Kidney Dis 1991;17:127–32
- Oliveira LG, Sass N, Sato JL. Pregnancy after renal transplantation – a five year single-center experience. Clin Transplant 2007;21:302–4
- Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741–51
- Cardonick E, Moritz M, Armenti V. Pregnancy in patients with organ transplantation: a review. Obstet Gynecol Surv 2004;59:214–22
- Pérgola PE, Kancharla A, Riley J. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplanation 2001;71:994–7
- Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res 2003;29:227–33
- Miroux C, Moralès O, Carpentier A, et al. Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc 2009;41:3371–74
- Groth K, Brännström M, Mölne J, Wranning CA. Cyclosporine A exposure during pregnancy in mice: effects on reproductive performance in mothers and offspring. Hum Reprod 2010;25:697–704
- Kusec V, Smalcelj R, Puretic Z, Szekeres P T. Interleukin-6, transforming growth factor-beta 1, and bone markers after kidney transplantation. Calcif Tissue Int 2004;75:1–6
- Brandacher G, Cakar F, Winkler C, et al. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int 2007;71:60–7
- Dimeny EM. Cardiovascular disease after renal transplantation. Kidney Int 2002;80:S78--S84
- Tosun M, Celik C, Avci B, et al. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. J Mat Fet Neonatal Med 2010;23:880–6
- Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 2011;56:550–9
- Jonsson Y, Ruber M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006;70:83–91
- Jones CA, Finlay-Jones JJ, Hart PH. Type-1 and type-2 cytokines in human late-gestation decidual tissue. Biol Reprod 1997;57:303–11
- Wilczyński JR. Th1/Th2 cytokines balance – yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 2005;122:136–43
- Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001;4:219–27
- Singh A, Sharma S, Raghunaandan C, Bhattacharjee J. Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of preeclampsia. Am J Reprod Immunol 2010;63:244–51
- Chen LM, Liu B, Zhao HB, et al. IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta 2010;31:75–80
- Schilling B, Yeh J. Transforming growth factor-beta(1), -beta(2), -beta(3) and their type I and II receptors in human term placenta. Gynecol Obstet Invest 2000;50:19–23
- Chai JG, Xue AS, Coe D, et al. Regulatory T cells, derived from naive CD4+. Transplantation 2005;79:1310–16
- Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell 2008;134:392–404
- Moraes-Vieira PM, Takenaka MC, Silva HM, et al. GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation. Clin Immunol 2012;142:117–26
- Blaschitz A, Gauster M, Fuchs D, et al. Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface. PLoS One [serial online] 2011; 6:e21774. Available: http:\\www.plosone.org\article\info%3Adoi%2F10.1371%2FJournal.PONE.0021774 [last acessed 10 Sep 2012]